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ScenARIo
i am a general dental practitioner practising in a small town. 
i was recently approached by a contract research organisa-
tion (CRO) to participate in a clinical trial of a new dental 
restorative material. i was offered a sum of money for each 
patient i enrolled in the trial. i was assured by the representa-
tive that the trial has received the necessary approvals, in-
cluding one from an Ethics Review committee. i have never 
participated in a clinical research trial before and am happy 
to receive the extra money. i joined the trial immediately, but 
am concerned now that i did not enquire further about the 
scientific or ethical aspects of the study. Should i withdraw 
from the trial?
commentARy
Dental materials and pharmaceutical products are required 
to have proven evidence of their safety and efficacy before 
governmental approval may be granted for their distribution 
and use. in the interest of the advancement of Dental Materi-
al Science towards the development of safe, efficacious and 
innovative treatment, scientifically valid and ethical research 
of high quality must be conducted. in the past few decades, 
great progress has been made in the development of new 
dental materials, devices and techniques and there is more 
dental research being carried out than ever before. The 
dental profession has a responsibility to be familiar with the 
guidelines and legislation related to research ethics. 
Research ethics involves the systematic analysis of ethical 
and legal questions to ensure that study participants are 
protected, and ultimately, that clinical research is conducted 
in a way that serves the needs of such participants and 
of society as a whole. Evidence-based decision making by 
dentists means that they are utilising the results of dental 
research in their clinical practice. it is a requirement of the 
Health Professions Council of South Africa (HPCSA) that all 
dentists must maintain their competence, and keep abreast 
with the current research in their area of practice through 
Continuing Professional Development, reading dentistry 
journals and interacting with knowledgeable colleagues. 
This ensures that even if dentists do not engage in research 
themselves, they are nevertheless familiar with basic re-
search methodology and are able to interpret the results of 
research and apply them in their daily practice. it is also a 
requirement of the HPCSA that there is incorporation of re-
search and ethics (including research ethics) components, 
together with consideration of human rights in the curricu-
lum for both undergraduate and postgraduate programmes 
at all levels of health sciences education. 
A clinical trial is one of the most common methods of research 
for comparing and evaluating new materials and drugs. Clini-
cal trials have contributed significantly to the knowledge base 
in dentistry and it is imperative that all such trials are conduct-
ed according to the principles of good clinical practice (GCP). 
The process usually begins with laboratory studies followed 
by testing on animals. if these prove promising, four phases 
of clinical research need to take place1:
Phase One research, conducted on a small number of •	
healthy volunteers, who are often paid for their participa-
tion, is intended to determine what dosage of a drug 
is required to produce a response in the human body, 
how the body processes the drug, and whether the drug 
produces toxic or harmful effects.
Phase Two research is conducted on a group of patients •	
who have the disease that the drug is intended to treat. 
its goals are to determine whether the drug produces 
any beneficial effect on the disease and whether there 
are any harmful side effects.
Phase Three research is the clinical trial, in which the drug •	
is administered to a large number of patients and com-
pared with another drug, if there is one for the condition 
in question and/or to a placebo. ideally, such trials are 
‘double-blinded’ i.e. neither research subjects nor their 
dentists know who is receiving which drug or placebo.
Phase Four research takes place after the drug is •	
licensed and marketed. For the first few years, a new 
drug is monitored for side effects.
Due to the rapid increase in recent years in the number of 
on-going trials, more and more patients are needed to meet 
the statistical requirements of the trials and many dentists 
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are being approached to enrol their patients as research sub-
jects into the trial. However, a dentist needs to consider this 
request carefully as there may be a conflict between the den-
tist as a clinician and the dentist as a researcher. it is the im-
portant to distinguish between the dentist-patient relationship 
in the clinical setting and the investigator-participant relation-
ship in research endeavours. Traditionally, the dentist-patient 
relationship is based on concern for individual patients and 
the patient is seen as the ultimate purpose and beneficiary. 
in research, the study participant may stand to benefit to a 
certain degree but the benefit to science and society may be 
significant enough to render the research participant a means 
to an end. Therefore the research participant requires special 
protection of his/her rights in such settings and the dentists 
needs to be aware of potential conflicts.2 
So what makes clinical research ethical? The following con-
cepts, adapted from Emanuel et al.3 have been described as 
the benchmarks of ethical research:
relevance, scientific, clinical and social value
A research project should contribute to the well-being of 
society in general and should expand scientific knowledge 
leading to an improvement in the overall health of the com-
munity. Research that lacks social or scientific value is un-
ethical as it results in a waste of limited resources and ex-
ploits human subjects by exposing them to potential harm. 
As resources available for research in health diminish so 
the issue of social value has become more important. The 
research objectives, for both scientific and social value, 
should outweigh the risks and burdens to research partici-
pants. The populations in which the research is carried out 
should benefit from the results of the research. This is espe-
cially important in countries where there is potential for unfair 
treatment of research participants who undergo the risks 
and discomfort of research for drugs and materials that are 
going to benefit only patients elsewhere.1
scientific validity
Research involving human subjects must be justifiable on 
scientific grounds and must be conducted in a methodolog-
ically sound and rigorous manner. This requirement entails 
that research protocols must ensure that the:
aims and objectives are clear and scientific;•	
study design is relevant and uses accepted principles;•	
sample size has sufficient power to definitively test the •	
objectives;
methods are valid, reliable and practically feasible;•	
data analysis is clear and plausible.•	
The ethical justification of scientific validity relies on the 
same principles that apply to the avoidance of exploita-
tion. if patients are being asked to participate in a research 
project, even where risk of harm is minimal, there should 
be an expectation that important scientific knowledge will 
be the result.
subject selection: must be fair and free from exploi-
tation of vulnerable groups
Research participants should be selected so as to minimise 
risks and to enhance benefits to them and to society as a 
whole. Decisions regarding recruitment, enrollment, inclusion 
into, and exclusion from, the study need to be fairly done ac-
cording to stated scientific aims and objectives and not ac-
cording to vulnerability, privilege or other unrelated purposes. 
in addition, participating individuals or groups who bear the 
risks and burdens of the research should be in a position 
to enjoy its benefits. The following groups of people are re-
garded as vulnerable research participants - children and 
adolescents, elderly, pregnant women, prisoners, people 
with mental disabilities, those with substance abuse disor-
ders and ‘vulnerable communities’. The UNAiDS has defined 
vulnerable communities as those with: limited economic de-
velopment, limited health care and treatment options, limited 
ability to provide individual informed consent, inadequate HR 
protection and discrimination based on health status and in-
adequate understanding of scientific research.
risk-benefit ratio
A researcher must be able to demonstrate that the risks to 
the research participants are not unreasonable or dispropor-
tionate to the expected benefits of the research. A risk is the 
potential for an adverse outcome (harm) to occur and has 
two components (i) the likelihood of the occurrence of harm 
(ranging from highly unlikely to very likely), and (ii) the severity 
of the harm (ranging from trivial to permanent severe disability 
or death). Researchers are required to adequately assess the 
risks and be sure that they can be managed. if the risk is en-
tirely unknown, then the researcher should not proceed with 
the project until some reliable data are available, for example, 
from laboratory studies or experiments on animals,1 as de-
tailed above in the recommended sequence of trials.
The requirement for a favourable risk-benefit ratio is based 
on the ethical principles of non-maleficence and benefi-
cence. Non-maleficence states that one ought not to inflict 
harm and this justifies the need to reduce risks associated 
with research. Beneficence refers to acting for the benefit of 
others and this translates into the need to enhance the po-
tential benefits of research to the both the study participant 
and to society as a whole.3 in many cases, clinical research 
involves drugs, devices and procedures about which there 
is limited knowledge. As such there is inherent uncertainty 
about the degree of risks and benefits associated with these 
experimental interventions. in any research endeavour the 
net expected benefit to patients must outweigh anticipated 
risks. Clinical research can be justified only if the:
potential risks to the individual participants are mini-•	
mised;
potential benefits to the individual participant are en-•	
hanced;
potential benefits to the individual participants and soci-•	
ety are proportionate to or outweigh the risks.
independent review
Conflict of interest may be defined as a “set of conditions in 
which professional judgement concerning primary interest 
(eg. validity of research) tends to be unduly influenced by a 
secondary interest (eg. financial gain)”.4 in clinical research, 
there are various levels where there may be a conflict of in-
terest for example in the actions of pharmaceutical industries 
and their relation to health professionals. Among research-
ers there may be conflicts related to financial gain associ-
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ated with participation in sponsored pharmaceutical trials. 
independent review helps to  minimise the potential of such 
conflicts of interest and safeguards social accountability. in 
some instances, it is difficult to say when a risk is justified in 
view of the possible benefits related to the research. in many 
cases participants may not always be able to fully appreci-
ate the risks associated with scientific research and tend to 
agree with whatever the health professional suggests. The 
researcher therefore has an obligation to exercise some re-
sponsibility over the risks to which participants are allowed 
to expose themselves.2 
in South Africa, all research proposals on human subjects 
must be reviewed and approved by an independent Research 
Ethics Committee (REC) before the project, whether clinical 
trials or primary research, can proceed. in order to obtain ap-
proval, researchers must include the purpose and methodol-
ogy of the proposed research; demonstrate how research 
subjects will be recruited, how their consent will be obtained 
and how their privacy will be protected; specify how the proj-
ect is being funded and disclose any potential conflicts of 
interest on the part of the researchers. Thereafter the Ethics 
Committee may approve the project as presented, require 
changes before it can start, or refuse approval altogether.
in addition, if a drug or device is involved, approval from the 
Medicines Control Council (MCC) is required in South Africa.
informed consent
The first principle of the Nuremberg Code5 reads as follows: 
“The voluntary consent of the human subject is absolutely 
essential” and requires, among other things, that the re-
search subject “should have sufficient knowledge and com-
prehension of the elements of the subject matter involved 
as to enable him/her to make an understanding and enlight-
ened decision”. Furthermore, research subjects should be 
informed that they are free to withdraw their consent to par-
ticipate at any time, even after the project has begun, with-
out any sort of reprisal from the researcher or dentist and 
without any compromise of their management and care.
individuals participating in clinical research must be able to 
make a voluntary and uncoerced decision regarding partici-
pation. in the research setting, obtaining informed consent 
is comprehensive and includes full disclosure/declaration 
of all anticipated risks including death. Therefore, to enable 
valid informed consent, research participants must be ac-
curately informed of the purpose, methods, risks, benefits 
and alternatives to the research and they must understand 
the information provided in order to make an informed deci-
sion about participation. in South Africa written consent is 
required in all research projects and, despite the many chal-
lenges that arise during the consent process, free, volun-
tary, valid, informed consent requires special consideration 
in oral health research.
respect for participants 
Respecting potential and enrolled participants includes: 
respect of privacy by maintaining confidentiality: unlike •	
clinical care, however, research requires the disclosure 
of personal health information to others, including the 
wider scientific community and sometimes the general 
public. in order to protect privacy, researchers must en-
sure that they obtain the informed consent of research 
subjects to use their personal health information for re-
search purposes, which requires that the subjects are 
told in advance about the uses to which their informa-
tion is going to be put. as a general rule, the informa-
tion should be de-identified and should be stored and 
transmitted securely to ensure anonymity;1
allowing participants to withdraw from the study without •	
penalty;
providing any new information (positive or negative) that •	
becomes available during the course of the study;
carefully monitoring the participants throughout the du-•	
ration of the study;
informing them about the outcomes of the research. •	
concLudIng RemARkS
As can be seen by the commentary above regarding some 
of the benchmarks of good ethical research, the practitioner 
in the depicted scenario should have considered all these 
aspects before accepting the offer to participate. More in-
formation regarding the project was required to ensure that 
it met all the requirements of carrying out ethical research. 
Written confirmation should have been requested showing 
that the protocol had been submitted to a REC and was 
approved without any comment or conditions on the study. 
While patient autonomy, informed consent, confidentiality, 
protection of privacy, professional competence, standards 
of care and rational, sound, scientific evidence are criti-
cal components in distinguishing between acceptable and 
unacceptable research, the determination is ultimately an 
ethical one and comes down to preparedness, clarity, 
transparency and respect for human rights and justice. 
Before participating in any research one should be satisfied 
with the scientific merit and social value of the research. if 
the dentist agrees to participate, then he/she should ensure 
that the risks, benefits and alternatives are clearly explained 
to the participant (patient) so that free, fully informed con-
sent can be obtained. The principle of discursive ethics that 
those who are affected by decisions should have a voice 
in the decisions means that the profession generally and 
society as a whole must also decide where the boundar-
ies of acceptable research practice lie. Dentist-researchers 
should act in the best interest of the patient and only en-
rol those who will not be harmed in any way. Research 
participants should be carefully monitored for unexpected 
adverse events and corrective action should be available if 
need be. Findings of the study should be communicated 
to the participants timeously. Knowledge of relevant laws 
and regulations, the maintenance of personal and profes-
sional integrity and detailed execution of the research pro-
posal is essential to ensure that the research aims and 
objectives are reached.
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